Pediatrix Medical Group, Inc. Shareholders' Equity
Pediatrix Medical Group, Inc. (MD) had Shareholders' Equity of $880.98 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $880.98M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $878.58M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $865.85M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $890.67M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $880.98M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $878.58M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $865.85M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $890.67M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $833.75M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $789.19M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $764.94M 10-K · filed 2026-02-19 |
| 2024-09-30 | $732.49M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $706.46M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $856.20M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $849.06M 10-K · filed 2025-02-20 |
| 2023-09-30 | $967.99M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $942.38M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $909.77M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $891.63M 10-K · filed 2024-02-20 |
| 2022-09-30 | $858.67M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $845.43M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $877.08M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $896.49M 10-K · filed 2023-02-17 |
| 2021-09-30 | $845.47M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $808.91M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $766.76M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $747.49M 10-K · filed 2022-02-17 |
| 2020-09-30 | $804.76M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $826.57M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $1.49B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.50B 10-K · filed 2021-02-18 |
| 2019-09-30 | $1.48B 10-Q · filed 2019-11-01 |
| 2019-06-30 | $2.73B 10-Q · filed 2019-08-01 |
| 2019-03-31 | $2.78B 10-Q · filed 2019-05-02 |
| 2018-12-31 | $3.09B 10-K · filed 2020-02-20 |
| 2018-09-30 | $3.02B 10-Q · filed 2018-11-01 |
| 2018-06-30 | $3.19B 10-Q · filed 2018-08-02 |
| 2018-03-31 | $3.14B 10-Q · filed 2018-05-04 |
| 2017-12-31 | $3.07B 10-K · filed 2019-02-14 |
| 2017-09-30 | $2.92B 10-Q · filed 2017-11-01 |
| 2017-06-30 | $2.84B 10-Q · filed 2017-07-28 |
| 2017-03-31 | $2.76B 10-Q · filed 2017-05-04 |
| 2016-12-31 | $2.76B 10-K · filed 2018-02-14 |
| 2016-09-30 | $2.67B 10-Q · filed 2016-10-27 |
| 2016-06-30 | $2.56B 10-Q · filed 2016-07-28 |
| 2016-03-31 | $2.46B 10-Q · filed 2016-04-28 |
| 2015-12-31 | $2.44B 10-K · filed 2017-02-10 |
| 2015-09-30 | $2.33B 10-Q · filed 2015-10-29 |
| 2015-06-30 | $2.22B 10-Q · filed 2015-07-30 |
| 2015-03-31 | $2.11B 10-Q · filed 2015-04-30 |
| 2014-12-31 | $2.26B 10-K · filed 2016-02-11 |
| 2014-09-30 | $2.50B 10-Q · filed 2014-10-30 |
| 2014-06-30 | $2.40B 10-Q · filed 2014-07-31 |
| 2014-03-31 | $2.31B 10-Q · filed 2014-05-01 |
| 2013-12-31 | $2.34B 10-K · filed 2015-02-09 |
| 2013-09-30 | $2.23B 10-Q · filed 2013-10-31 |
| 2013-06-30 | $2.19B 10-Q · filed 2013-07-30 |
| 2013-03-31 | $2.11B 10-Q · filed 2013-05-02 |
| 2012-12-31 | $2.04B 10-K · filed 2014-02-12 |
| 2012-09-30 | $1.95B 10-Q · filed 2012-11-01 |
| 2012-06-30 | $1.87B 10-Q · filed 2012-07-31 |
| 2012-03-31 | $1.80B 10-Q · filed 2012-05-03 |
| 2011-12-31 | $1.73B 10-K · filed 2014-02-12 |
| 2011-09-30 | $1.66B 10-Q · filed 2011-11-01 |
| 2011-06-30 | $1.59B 10-Q · filed 2011-08-02 |
| 2011-03-31 | $1.51B 10-Q · filed 2011-05-03 |
| 2010-12-31 | $1.45B 10-K · filed 2014-02-12 |
| 2010-09-30 | $1.37B 10-Q · filed 2010-11-03 |
| 2010-06-30 | $1.30B 10-Q/A · filed 2010-08-31 |
| 2009-12-31 | $1.19B 10-K · filed 2013-02-15 |
| 2008-12-31 | $965.14M 10-K · filed 2012-02-29 |
| 2007-12-31 | $959.05M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |